GOVX
GOVX
NASDAQ · Biotechnology

Geovax Labs Inc

$0.72
+0.00 (+0.03%)
As of Aug 15, 2:39 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +2,221.7% upside
Low Target $13.69
Average Target $16.67
High Target $25.88
Current Price $0.72
Current
$0.72
Target
$16.67
$13.69 $16.67 avg $25.88
Scenario Analysis
Bear Case
$13.69
1,806.7%
Low target
Base Case
$16.67
+2,221.7%
Avg target
Bull Case
$25.88
+3,504.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$20.00
-96.4% from high
52-Week Low
$0.64
+12.4% from low
Target vs 52W High
$16.67
-16.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%